Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

SIOG 2017

9 - 11 Nov 2017

Hilton Warsaw Hotel and Convention Centre, Warsaw, Poland

Bevacizumab and colorectal cancer in geriatrics

Thomas Aparicio - Hôpital Saint-Louis, Paris, France

Bevacizumab and colorectal cancer in geriatrics ( Thomas Aparicio - Hôpital Saint-Louis, Paris, France )

Patient adherence to oral therapies

Dr Ginah Nightingale - Thomas Jefferson University, Philadelphia, USA

Patient adherence to oral therapies ( Dr Ginah Nightingale - Thomas Jefferson University, Philadelphia, USA )

Communication with elderly patients is important for assessment

Dr Fábio Gomes - The Christie NHS Foundation Trust, Manchester, UK

Communication with elderly patients is important for assessment ( Dr Fábio Gomes - The Christie NHS Foundation Trust, Manchester, UK )

Concluding the debate around dexrazoxane

Dr Etienne Brain - Institut Curie, Paris, France

Concluding the debate around dexrazoxane ( Dr Etienne Brain - Institut Curie, Paris, France )

Cardiovascular toxicities from cancer treatment

Dr Chris Plummer - Freeman Hospital, Newcastle, UK

Cardiovascular toxicities from cancer treatment ( Dr Chris Plummer - Freeman Hospital, Newcastle, UK )

The promise of immunotherapy for elderly patients

Dr Alistair Greystoke - Newcastle University, Newcastle, UK

The promise of immunotherapy for elderly patients ( Dr Alistair Greystoke - Newcastle University, Newcastle, UK )

Making lifestyle decisions surrounding geriatric cancer surgery

Prof Mike Jaklitsch - Harvard Medical School, Boston, USA

Making lifestyle decisions surrounding geriatric cancer surgery ( Prof Mike Jaklitsch - Harvard Medical School, Boston, USA )

Toxicities in treatments of lung cancers with respect to the elderly

Dr Lore Decoster - UZ Brussel, Brussels, Belgium

Toxicities in treatments of lung cancers with respect to the elderly ( Dr Lore Decoster - UZ Brussel, Brussels, Belgium )

Communicating with geriatric patients

Prof Karis Kin‐Fong Cheng - NUS Yong Loo Lin School of Medicine, Singapore

Communicating with geriatric patients ( Prof Karis Kin‐Fong Cheng - NUS Yong Loo Lin School of Medicine, Singapore )

Utility and application of cancer screening in geriatrics

Dr Shabbir Alibhai - Princess Margaret Cancer Centre, Toronto, Canada

Utility and application of cancer screening in geriatrics ( Dr Shabbir Alibhai - Princess Margaret Cancer Centre, Toronto, Canada )

Treating AML in patients over 70

Dr Martine Extermann - Moffitt Cancer Center, Tampa, USA

Treating AML in patients over 70 ( Dr Martine Extermann - Moffitt Cancer Center, Tampa, USA )

Benefits and drawbacks of dexrazoxane

Dr Robin Jones - The Institute of Cancer Research, London, UK

Benefits and drawbacks of dexrazoxane ( Dr Robin Jones - The Institute of Cancer Research, London, UK )

A formulated geriatric assessment and the role of nurses

Dr Martine Puts - University of Toronto, Toronto, Canada

A formulated geriatric assessment and the role of nurses ( Dr Martine Puts - University of Toronto, Toronto, Canada )

Encouraging age related reviews of three new breast cancer treatments

Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium

Encouraging age related reviews of three new breast cancer treatments ( Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium )

Screening tools in geriatric oncology

Prof Cindy Kenis - University Hospital Leuven, Leuven, Belgium

Screening tools in geriatric oncology ( Prof Cindy Kenis - University Hospital Leuven, Leuven, Belgium )

VESPA: a tool for assessing outcomes in a post operative setting

Dr YaoYao Pollock - UCSF School of Medicine, San Francisco, USA

VESPA: a tool for assessing outcomes in a post operative setting ( Dr YaoYao Pollock - UCSF School of Medicine, San Francisco, USA )

Improving eligibility for the elderly in clinical trails

Dr Stuart Lichtman - Memorial Sloan Kettering Cancer Center, New York, USA

Improving eligibility for the elderly in clinical trails ( Dr Stuart Lichtman - Memorial Sloan Kettering Cancer Center, New York, USA )

Cancer treatment related fatigue in the elderly

Prof Claire Falandry - Lyon University, Lyon, France

Cancer treatment related fatigue in the elderly ( Prof Claire Falandry - Lyon University, Lyon, France )

Treatments for elderly head and neck cancer patients

Dr Ronald Maggiore - University of Rochester, New York, USA

Treatments for elderly head and neck cancer patients ( Dr Ronald Maggiore - University of Rochester, New York, USA )

Health related quality of life as a potential predictor for mortality

Dr Clark DuMontier - Harvard Medical School / Beth Israel Deaconess Medical Center, Boston, USA

Health related quality of life as a potential predictor for mortality ( Dr Clark DuMontier - Harvard Medical School / Beth Israel Deaconess Medical Center, Boston, USA )

Raising awareness of cognitive impairment in elderly patients

Dr Carla Ripamonti - Instituto Nazionale dei Tumori, Milan, Italy

Raising awareness of cognitive impairment in elderly patients ( Dr Carla Ripamonti - Instituto Nazionale dei Tumori, Milan, Italy )

Caring for elderly cancer patients

Dr Beatriz Korc-Grodzicki - Memorial Sloan Kettering Cancer Center, New York, USA

Caring for elderly cancer patients ( Dr Beatriz Korc-Grodzicki - Memorial Sloan Kettering Cancer Center, New York, USA )

More from ecancer